Jim Simons Nuwellis, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.56 - $2147.95 $7,840 - $30.1 Million	14,000 Added 8.27%	183,200 $99,000
Q2 2022 Aug 12, 2022	SELL	$0.48 - $1.12 $6,432 - $15,008	-13,400 Reduced 7.34%	169,200 $100,000
Q1 2022 May 13, 2022	SELL	$0.85 - $1.27 $19,550 - $29,210	-23,000 Reduced 11.19%	182,600 $184,000
Q4 2021 Feb 11, 2022	BUY	$1.13 - $2.26 $31,643 - $63,286	28,003 Added 15.77%	205,600 $234,000
Q3 2021 Nov 12, 2021	BUY	$2.12 - $4.6 $260,117 - $564,406	122,697 Added 223.49%	177,597 $391,000
Q2 2021 Aug 13, 2021	BUY	$3.53 - $5.98 $193,797 - $328,302	54,900 New	54,900 $231,000

Ticker NUWE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,531,600
Market Cap $41.6M
Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.